Human tumor antigens for cancer vaccine development, Immunol. Rev, vol.170, pp.85-100, 1999. ,
A listing of human tumor antigens recognized by T cells, Cancer Immunol. Immunother, vol.50, pp.3-15, 2001. ,
The cancer/testis genes: review, standardization, and commentary, Cancer Immun, vol.4, p.1, 2004. ,
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8 + T cells in melanoma patients, J. Immunol, vol.165, pp.533-538, 2000. ,
Part I: Vaccines for solid tumours, Lancet Oncol, vol.5, pp.681-689, 2004. ,
Rational peptide-based tumour vaccine development and T cell monitoring, Semin. Cancer Biol, vol.13, pp.423-429, 2003. ,
Enhanced generation of specific tumorreactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J. Immunol, vol.160, pp.1750-1758, 1998. ,
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope, Int. J. Cancer, vol.70, pp.302-309, 1997. ,
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues, Int. Immunol, vol.11, pp.1971-1980, 1999. ,
Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis, Nature, vol.352, pp.67-70, 1991. ,
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T cell stimulation, Nature, vol.346, pp.574-576, 1990. ,
Heterogeneous T cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity, Cancer Res, vol.61, pp.5850-5856, 2001. ,
Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class Itransgenic mice, J. Immunol, vol.167, pp.5824-5831, 2001. ,
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluoresceinlabeled synthetic peptides, Hum. Immunol, vol.64, pp.245-255, 2003. ,
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays, Mol. Immunol, vol.31, pp.813-822, 1994. ,
The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice, J. Immunol, vol.164, pp.2354-2361, 2000. ,
Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8 + T cells, J. Immunol, vol.170, pp.1822-1829, 2003. ,
Recombinant antibodies with MHC-restricted, peptide-specific, T cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions, J. Mol. Recognit, vol.16, pp.324-332, 2003. ,
Genetic engineering of T cell specificity for immunotherapy of cancer, Hum. Immunol, vol.64, pp.56-68, 2003. ,
A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3, Eur. J. Immunol, vol.24, pp.3038-3043, 1994. ,
Magnetofluorescent liposomes for increased sensitivity of immunofluorescence, Immunotechnology, vol.1, pp.127-137, 1995. ,
Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity, J. Immunol, vol.167, pp.787-796, 2001. ,
Pre-existing immunity to tyrosinaserelated protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy, J. Immunol, vol.168, pp.951-956, 2002. ,
Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response, J. Immunol, vol.172, pp.1582-1587, 2004. ,
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments, Eur. J. Immunol, vol.34, pp.2919-2929, 2004. ,
Modification of a tumorderived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies, J. Immunol, vol.169, pp.4399-4407, 2002. ,
TCRs with high affinity for foreign pMHC show self-reactivity, Nat. Immunol, vol.4, pp.55-62, 2003. ,
Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts, J. Biol. Chem, vol.276, pp.21443-21449, 2001. ,
Modification of peptide interaction with MHC creates TCR partial agonists, Cell. Immunol, vol.227, pp.70-78, 2004. ,
Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2 M is correlated to TCR avidity, J. Immunol, vol.169, pp.531-539, 2002. ,
T cell killing does not require the formation of a stable mature immunological synapse, Nat. Immunol, vol.5, pp.524-530, 2004. ,
An alphabeta T cell receptor structure at 2.5 and its orientation in the TCR-MHC complex, Science, vol.274, pp.209-219, 1996. ,
Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes, J. Immunol, vol.171, pp.3064-3074, 2003. ,
Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR, J. Immunol, vol.167, pp.270-276, 2001. ,
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation, Immunity, vol.18, pp.255-264, 2003. ,
Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies, J. Immunol, vol.170, pp.4349-4361, 2003. ,
Quantitating protein synthesis, degradation, and endogenous antigen processing, Immunity, vol.18, pp.343-354, 2003. ,
Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies, J. Immunol, vol.164, pp.5626-5634, 2000. ,
Direct detection and quantitation of a distinct T cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells, Cancer Res, vol.62, pp.5835-5844, 2002. ,
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody, Immunity, vol.6, pp.715-726, 1997. ,
Generation of cytotoxic T cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens, Int. J. Cancer, vol.66, pp.162-169, 1996. ,
Lipid rafts mediate association of LFA-1 and CD3 and formation of the immunological synapse of CTL, J. Immunol, vol.173, pp.2960-2967, 2004. ,
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides, Proc. Natl. Acad. Sci, vol.89, pp.3429-3433, 1992. ,
Clonal expansion of lymphocytes bearing the gamma delta T cell receptor in a patient with large granular lymphocyte disorder, Blood, vol.74, pp.285-290, 1989. ,
T cell growth factor receptors. Quantitation, specificity, and biological relevance, J. Exp. Med, vol.154, pp.1455-1474, 1981. ,